eFFECTOR Therapeutics, Inc.
(NASDAQ : EFTR)

( )
EFTR After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Finance » Financial Conglomerates
symbolcompany%chnglast%shortavg$volume
CCitigroup, Inc. 2.15%72.321.0%$1458.68m
LCIDLucid Group, Inc. 0.29%24.080.0%$1057.61m
AXPAmerican Express Co. 2.54%175.861.7%$619.90m
GWHESS Tech, Inc. 3.07%17.460.0%$324.92m
RIOTRiot Blockchain, Inc. 6.62%27.850.0%$271.48m
PRUPrudential Financial, Inc. 0.71%110.561.5%$224.24m
DOCNDigitalOcean Holdings, Inc. -1.42%89.080.0%$221.14m
JXNJackson Financial, Inc. (Michigan) -2.55%28.120.0%$110.00m
EQHEquitable Holdings, Inc. -1.02%32.040.0%$81.17m
OPADOfferpad Solutions, Inc. 1.10%8.270.0%$66.40m
EXPIeXp World Holdings, Inc. 1.89%48.590.0%$56.58m
INGING Groep NV 1.62%15.090.2%$50.92m
TMCTMC the metals co., Inc. 2.20%3.710.0%$43.72m
IONQIonQ, Inc. 1.83%10.000.0%$40.01m
GGPIGores Guggenheim, Inc. -0.50%10.010.0%$37.44m

Company Profile

eFFECTOR Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on the development of a new class oncology drugs known as selective translation regulator inhibitors (STRIs). Its STRI product candidates target the eIF4F complex and its activating kinase, mitogen-activated protein kinase 1/2 (MNK 1/2). The company was founded by Kevan Shokat, Davide Ruggero, and Siegfried Reich on May 1, 2012 and is headquartered in San Diego, CA.